Hematology & Oncology Doctors in Kalispell, MT Accepting Medicare

5 Hematology & Oncology doctors found. Showing 1 - 5

Dr. William M Boehme, MD Internal Medicine - Hematology & Oncology Medicare: Not Enrolled in Medicare Practice Location: 350 Heritage Way, Suite 1100, Kalispell, MT 59901 Phone: 406-752-8900    Fax: 406-752-8909

Peter Wagner, MD Internal Medicine - Hematology & Oncology Medicare: Accepting Medicare Assignments Practice Location: 350 Heritage Way, Suite 1100, Kalispell, MT 59901 Phone: 406-752-8900    Fax: 406-752-8909

Elise Anderes, MD Internal Medicine - Hematology & Oncology Medicare: Accepting Medicare Assignments Practice Location: 350 Heritage Way, Suite 1100, Kalispell, MT 59901 Phone: 406-752-8900    Fax: 406-752-8909

John A Ward, MD Internal Medicine - Hematology & Oncology Medicare: Not Enrolled in Medicare Practice Location: 350 Heritage Way, Suite 1100, Kalispell, MT 59901 Phone: 406-752-8900    Fax: 406-752-8909

Karen J Hunt, MD Internal Medicine - Hematology & Oncology Medicare: Not Enrolled in Medicare Practice Location: 350 Heritage Way, Suite 1100, Kalispell, MT 59901 Phone: 406-752-8900    Fax: 406-752-8909

News Archive

Important to fund the GAFSP now

In a Guardian opinion piece, Lael Brainard, under-secretary for international affairs at the U.S. Treasury, writes about the importance of funding the Global Agriculture and Food Security Program (GAFSP) and investing in small farmers in the developing world.

FDA makes moves to block foreign drug imports

The Food and Drug Administration today announced a new partnership with the Virginia Pharmacists Association to distribute consumer educational materials outlining the risks of purchasing medicines outside of FDA's regulatory scope. Over the past month, FDA has co-sponsored agreements with state pharmacists associations in Illinois, California, Texas, Maryland, New York, and Nebraska, and the Agency anticipates that additional agreements will be signed in the weeks ahead.

FDA approves Lannett's Hydromorphone Hydrochloride Tablets

Lannett Company, Inc. today announced that it has received approvals from the U.S. Food and Drug Administration (FDA) of its Abbreviated New Drug Applications (ANDAs) for Hydromorphone Hydrochloride Tablets USP, 2 mg, 4 mg and 8 mg, the generic equivalent of Purdue Pharmaceuticals' (formerly Abbott's) Dilaudid® Tablets 2 mg, 4 mg and 8 mg.

McGill researchers identify key mechanism by which environmental factors influence traits

Until now scientists have believed that the variations in traits such as our height, skin colour, tendency to gain weight or not, intelligence, tendency to develop certain diseases, etc., all of them traits that exist along a continuum, were a result of both genetic and environmental factors. But they didn't know how exactly these things worked together.

Read more Medical News

› Verified 4 days ago